DRAP approved the production of Bosch’s Remdesivir to treat COVID-19 patients.
We are pleased to announce approval of two manufacturing units by DRAP to produce remdesivir to treat COVID 19 patients. Bosch Pharmaceuticals is pioneer in Pakistan for lyophilized injectables, the only manufacturer with two lyophilization units making us the largest lyophilized product manufacturers.
Bosch Pharmaceuticals is pleased to announce approval of their two manufacturing units by DRAP to produce Remdesivir 100mg Lyophilized Vial to treat COVID-19 Patients in Pakistan.
Bosch Pharmaceuticals is Pakistan’s Pioneer producer of Lyophilized Injectables with an experience of over 15 years in Lyophilization process. We are the only manufacturer having two Lyophilization facilities making us the largest lyophilized product manufacturer in the country.
We are thankful to DRAP for their confidence on Bosch’s Quality, Expertise and Capacity and give assurance that in this time of crises Bosch will play its responsible role to provide quality product from US FDA Approved source of Raw Material.
We also give assurance to our medical professional that soon they will get Bosch’s Remdesivir 100mg Lyophilized Vial for treatment of their COVID-19 patients at a very economical price keeping up with our mission to provide quality medicine at an affordable price for all classes of patients.
Being a global healthcare company with presence in multiple countries across the world, after meeting local requirements we will also be exporting Remdesivir 100mg Lyophilized Vial globally taking quality image of Pakistan and Bosch the world over.
We’d like to thank our medical professionals for their confidence on Bosch’s quality products for the past 25 years and assure them that we will continue to launch latest therapies to serve the ailing humanity.